What are the recommended dosing instructions for rizatriptan in adults, elderly patients, and adolescents?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Rizatriptan Dosing Instructions

For adults, use rizatriptan 5 mg or 10 mg orally at migraine onset, with the 10 mg dose providing greater efficacy but more adverse effects; for pediatric patients ages 6-17 years, dose by weight: 5 mg for those <40 kg and 10 mg for those ≥40 kg. 1

Adult Dosing

Starting dose: Either 5 mg or 10 mg orally for acute migraine treatment 1

  • The 10 mg dose is more effective than 5 mg but carries higher risk of adverse effects
  • If headache returns after initial response, a second dose may be given 2 hours after the first dose
  • Maximum daily dose: 30 mg in any 24-hour period (up to 3 doses of 10 mg) 1
  • Safety of treating more than 4 headaches per 30-day period has not been established 1

Critical Dosing Adjustment for Propranolol Users

Adults on propranolol: Use only 5 mg rizatriptan, maximum 3 doses in 24 hours (15 mg total) 1. This is a mandatory dose reduction due to drug interaction that increases rizatriptan exposure.

Pediatric Dosing (Ages 6-17 Years)

Weight-based dosing: 1

  • <40 kg (88 lb): 5 mg dose
  • ≥40 kg (88 lb): 10 mg dose

Important pediatric restrictions:

  • Only one dose per 24 hours - efficacy and safety of multiple doses within 24 hours not established in children 1
  • Pediatric patients on propranolol:
    • If ≥40 kg: single 5 mg dose only (maximum 5 mg in 24 hours)
    • If <40 kg: Do not prescribe rizatriptan - contraindicated in this population when on propranolol 1

The pediatric approval is supported by trials showing rizatriptan achieved headache relief in 74% of attacks at 2 hours versus 36% with placebo 2, with consistent efficacy across both treated attacks 2. The 2020 pediatric migraine guideline recommends rizatriptan ODT (orally disintegrating tablet) as a treatment option for adolescents 3.

Elderly Patients

No dose adjustment required - pharmacokinetic studies show similar drug exposure in elderly versus young adults 4. Standard adult dosing applies.

Clinical Context from Guidelines

The 2025 American College of Physicians guideline positions triptans (including rizatriptan) as add-on therapy when NSAIDs or acetaminophen at adequate doses fail to provide sufficient pain relief 5. Counsel patients to treat early in the attack and consider combining rizatriptan with an NSAID or acetaminophen to improve efficacy 5, 3.

Key Safety Warnings

  • Medication overuse headache: Avoid using acute migraine medications ≥10 days per month 5, 1
  • Cardiovascular contraindications: Do not use in patients with coronary artery disease, stroke/TIA history, or uncontrolled hypertension 1
  • Serotonin syndrome risk: Exercise caution when combining with SSRIs, SNRIs, TCAs, or MAO inhibitors 1

When Triptans Fail

If one triptan is ineffective, try another triptan or an NSAID-triptan combination 3. For patients with rapid pain spike, consider non-oral triptan formulations 3. If nausea/vomiting is prominent, use non-oral triptan or add antiemetic 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.